Novartis is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and to enhance the quality of life. We also seek to provide a return to shareholders that reflects our performance and to adequately reward those who invest ideas and resources in our company. – Created in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis is currently organized into three divisions: – Pharmaceuticals, which comprises our activities in innovation-driven prescription medicines – Sandoz, which comprises our activities in generic prescription drugs – Consumer Health, which comprises activities in OTC, Animal Health, Medical Nutrition, Gerber (formerly Infant & Baby) and CIBA Vision